Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1126/science.abe4747

http://scihub22266oqcxt.onion/10.1126/science.abe4747
suck pdf from google scholar
33154108!7857400!33154108
unlimited free pdf from europmc33154108    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 235.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid33154108      Science 2020 ; 370 (6523): 1479-1484
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2 #MMPMID33154108
  • Xiang Y; Nambulli S; Xiao Z; Liu H; Sang Z; Duprex WP; Schneidman-Duhovny D; Zhang C; Shi Y
  • Science 2020[Dec]; 370 (6523): 1479-1484 PMID33154108show ga
  • Cost-effective, efficacious therapeutics are urgently needed to combat the COVID-19 pandemic. In this study, we used camelid immunization and proteomics to identify a large repertoire of highly potent neutralizing nanobodies (Nbs) to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein receptor binding domain (RBD). We discovered Nbs with picomolar to femtomolar affinities that inhibit viral infection at concentrations below the nanograms-per-milliliter level, and we determined a structure of one of the most potent Nbs in complex with the RBD. Structural proteomics and integrative modeling revealed multiple distinct and nonoverlapping epitopes and indicated an array of potential neutralization mechanisms. We bioengineered multivalent Nb constructs that achieved ultrahigh neutralization potency (half-maximal inhibitory concentration as low as 0.058 ng/ml) and may prevent mutational escape. These thermostable Nbs can be rapidly produced in bulk from microbes and resist lyophilization and aerosolization.
  • |Angiotensin-Converting Enzyme 2/chemistry/genetics/immunology[MESH]
  • |Animals[MESH]
  • |Antibodies, Neutralizing/chemistry/genetics/*immunology[MESH]
  • |Antibodies, Viral/chemistry/genetics/*immunology[MESH]
  • |Antibody Affinity[MESH]
  • |COVID-19/therapy[MESH]
  • |Camelids, New World[MESH]
  • |Escherichia coli[MESH]
  • |Humans[MESH]
  • |Neutralization Tests[MESH]
  • |Protein Binding[MESH]
  • |Protein Domains[MESH]
  • |Receptors, Virus/chemistry/genetics/immunology[MESH]
  • |Recombinant Proteins/chemistry/genetics/immunology[MESH]
  • |SARS-CoV-2/*immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box